Fine Foods & Pharmaceuticals N.T.M. S.p.A. Profit Margin

The latest profit margin for FF.MI is -0.42% as of June 2026. That compares with 4.98% in the prior-year period — down 108.4% year over year. That is below the sector sector average of 13.23%. Investors often review this figure alongside Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, FF.MI's profit margin moved from 4.98% to -0.42% — a 108.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s valuation or profitability profile.

Against its sector companies, FF.MI currently prints -0.42% for profit margin, while the sector average sits near 13.23%. That is roughly 103.2% below the sector mean. Large gaps often invite a closer look at Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Fine Foods & Pharmaceuticals N.T.M. S.p.A. converts resources into returns. At -0.42%, FF.MI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 4.98% in the prior-year period — down 108.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting FF.MI's profit margin (-0.42%), review year-over-year change from 4.98%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.